Powder: -20°C for 3 years | In solvent: -80°C for 1 year
CCT020312 is a selective activator of EIF2AK3 and PERK. CCT020312 durably inhibits cell proliferation and elicits the phosphorylation of EIF2A.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 63.00 | |
5 mg | In stock | $ 146.00 | |
10 mg | In stock | $ 255.00 | |
25 mg | In stock | $ 429.00 | |
50 mg | In stock | $ 635.00 | |
100 mg | In stock | $ 883.00 | |
500 mg | In stock | $ 1,830.00 |
Description | CCT020312 is a selective activator of EIF2AK3 and PERK. CCT020312 durably inhibits cell proliferation and elicits the phosphorylation of EIF2A. |
In vitro | In HT29 cells, CCT020312 reduces the P-S608-pRB signal with a linear response between 1.8 and 6.1 μM in a concentration-dependent manner. CCT020312(10 μM) decreases G1/S cyclins D1, D2, E, and A, reduces the CDK catalytic subunit CDK2 and increased the level of the p27KIP1[1]. |
In vivo | In wild-type mice, intraperitoneal injection of CCT020312 (1-5 mg/kg) increases PERK and NRF2 phosphorylation of brain homogenates. In P301S tau transgenic mice, intraperitoneal injection of CCT020312 (2 mg/kg) behaves better in the Morris water maze test[2]. |
Molecular Weight | 650.4 |
Formula | C31H30Br2N4O2 |
CAS No. | 324759-76-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 90.0 mg/mL (138.4 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
CCT020312 324759-76-4 Apoptosis PERK CCT-020312 CCT 020312 inhibitor inhibit